170 related articles for article (PubMed ID: 22773008)
1. Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine.
de Lima Aires A; de Azevedo Albuquerque MC; Silva RA; Schirato GV; de Pontes Filho NT; de Araújo SB; Souza VM; Costa VM; Malagueño E
Parasitol Res; 2012 Oct; 111(4):1569-78. PubMed ID: 22773008
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
[TBL] [Abstract][Full Text] [Related]
3. Schistosomicidal, hepatoprotective and antioxidant activities of the N-acetyl-L-cysteine and/or praziquantel in experimental acute mansonic schistosomiasis.
de Lima Aires A; de Araújo HDA; Galvão AM; de Araújo SB; da Silva RL; Dos Anjos ZP; de Souza Maia MB; Souza VMO; de Azevedo Albuquerque MCP
3 Biotech; 2023 Jun; 13(6):215. PubMed ID: 37251728
[TBL] [Abstract][Full Text] [Related]
4. Schistosomicidal, antifibrotic and antioxidant effects of Cucurbita pepo L. seed oil and praziquantel combined treatment for Schistosoma mansoni infection in a mouse model.
Beshay EVN; Rady AA; Afifi AF; Mohamed AH
J Helminthol; 2019 May; 93(3):286-294. PubMed ID: 29655377
[TBL] [Abstract][Full Text] [Related]
5. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
7. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis.
Soliman MF
Acta Trop; 2012 Jun; 122(3):261-6. PubMed ID: 22342904
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
Santos MP; Gonçalves-Santos E; Gonçalves RV; Santos EC; Campos CC; Bastos DSS; Marques MJ; Souza RLM; Novaes RD
Int Immunopharmacol; 2021 May; 94():107462. PubMed ID: 33611055
[TBL] [Abstract][Full Text] [Related]
10. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
11. Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
Atwa MTM; Abd-Elrazek AM; Salem NIS
Acta Parasitol; 2022 Jun; 67(2):773-783. PubMed ID: 35067863
[TBL] [Abstract][Full Text] [Related]
12. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855
[TBL] [Abstract][Full Text] [Related]
13. An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice.
Salama WM; El-Naggar SA; Harras SF; El-Said KS
Trop Biomed; 2021 Jun; 38(2):205-213. PubMed ID: 34172712
[TBL] [Abstract][Full Text] [Related]
14. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Abd El-Aal NF; Hamza RS; Harb O
Exp Parasitol; 2017 Dec; 183():23-32. PubMed ID: 29037782
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycemic and energy load differentially modulates Schistosoma mansoni-induced granulomatous inflammation and response to antiparasitic chemotherapy.
Reis LFCD; Cerdeira CD; Silva LCC; Ramos ABSB; Silva JEC; Castro AP; Ventura RR; Souza RLM; Marques MJ; Novaes RD
Acta Trop; 2024 Apr; 252():107141. PubMed ID: 38342286
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
Botros SS; Hammam O; Mahmoud M; Bergquist R
APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
[TBL] [Abstract][Full Text] [Related]
20. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
